Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06804395 · ClinicalTrials.gov registry record
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
A clinical trial of Cancer Risk, sponsored by Hackensack Meridian Health.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06804395 is a study of Cancer Risk that is actively recruiting participants, run by Hackensack Meridian Health. The registered enrollment target is 10,000 participants, below the 12,600-participant average among 7 other Cancer Risk trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06804395, a study of Cancer Risk, is actively recruiting participants, sponsored by Hackensack Meridian Health.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will prospectively collect data from participants in the form of questionnaires. The registry will also capture data that is collected as per non-research assessments, for participants who consent to participate. The registry will facilitate better understanding of cancer risk, screening, and diagnostics.
Conditions Studied
Study Locations (1)
New Jersey
- Hennessy Institute for Cancer Prevention and Applied Molecular Medicine - Totowa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2034-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06804395
The ClinicalTrials.gov registry entry for NCT06804395 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,600-participant average among 7 other Cancer Risk trials with a reported enrollment target (21% lower). The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer Risk appearing as the primary indexed condition, and to 0 interventions.
NCT06804395 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06804395 about?
NCT06804395 is a clinical study titled "CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management". Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science ...
What is the current status of trial NCT06804395?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2024-10-01. Estimated completion is 2034-10-01.
What conditions does trial NCT06804395 study?
This clinical trial studies the following conditions: Cancer Risk.
Who is sponsoring clinical trial NCT06804395?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06804395 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
RECRUITING · NA
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
-
Norris ORIEN Total Cancer Care
RECRUITING
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Morehouse Total Cancer Care Protocol
RECRUITING
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.